This inventor holds 5 USPTO granted patents and 7 published patent applications and 3 EPO patents. Top assignees: Dsm IP Assets B.v., Roche Vitamins Inc.. Active years: 2003-2024.
Location History:
- Stein, CH (2003)
- Rheinfelden, CH (2004)
- Muttenz, CA (2014)
- Basel, CH (2017)
- Kaiseraugst, CH (2024)
Company Filing History:
Years Active: 2003-2024
Title: Innovations by Inventor Markus Nowotny
Introduction
Markus Nowotny is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of medicaments and solid lipid nanoparticles. With a total of 5 patents, his work has had a considerable impact on improving drug formulations.
Latest Patents
One of his latest patents is focused on medicaments containing riboflavin that exhibit improved flowability. This innovation addresses the challenges faced by antihypertensive agents, which often have poor flowability properties due to their crystalline structure. The addition of spray-dried riboflavin has surprisingly enhanced the flowability of these agents. Another significant patent involves the development of new food-grade solid lipid nanoparticles, detailing their production and potential applications.
Career Highlights
Throughout his career, Markus Nowotny has worked with prominent companies such as Dsm IP Assets B.V. and Roche Vitamins Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to various projects that enhance drug delivery systems.
Collaborations
Markus has collaborated with several professionals in his field, including Guido Schaer and Raphael Beumer. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical technology.
Conclusion
Markus Nowotny's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of more effective drug formulations and delivery systems.